✦ LIBER ✦

Etoposide and thiotepa followed by ABMT (autologous bone marrow transplantation) in children and young adults with high-grade gliomas

✍ Scribed by E. Bouffet; C. Mottolese; A. Jouvet; I. Philip; D. Frappaz; C. Carrie; M. Brunat-Mentigny

Book ID: 117663626
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 656 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(96)00369-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose therapy followed by autologous

High-dose therapy followed by autologous bone marrow transplantation (ABMT) in previously untreated non-Hodgkin's lymphoma

✍ Sante Tura; Patrizio Mazza; Filippo Gherlinzoni; Paolo Ricci; Giuseppe Visani; G 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB

260 High-dose chemotherapy (HDC) followe

260 High-dose chemotherapy (HDC) followed by autologous bone marrow transplantation (ABMT) in place of craniospinal irradiation (RXT) in young children treated for medulloblastoma (MB)?

✍ O. Hartmann; D. Valteau-Couanet; S. Dupuis; F. Doz; J.C. Gentet; F. Méchinaud; E 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 163 KB

High-dose chemotherapy with etoposide, c

High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot study

✍ Ibrahim, Amad; Zambon, Edmilson; Bourhis, Jean H.; Ostronoff, Maurice; Beaujean, 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 844 KB

High-dose busulfan-thiotepa with autolog

High-dose busulfan-thiotepa with autologous stem cell transplantation followed by posterior fossa irradiation in young children with classical or incompletely resected medulloblastoma

✍ Bergthold, Guillaume; Kababri, Maria El; Varlet, Pascale; Dhermain, Frederic; Sa 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB

Intensive chemotherapy with high doses o

Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies

✍ M. H. Gaspard; D. Maraninchi; A. M. Stoppa; J. A. Gastaut; G. Michel; N. Tubiana 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 688 KB

Twenty-six patients (median age 33 years) with poor-risk malignancies were treated with high-dose combination chemotherapy associating BCNU-etoposide-cytosine arabinoside and melphalan (BEAM) followed by autologous bone marrow transplantation (ABMT). Twenty-one patients had malignant lymphomas, thre

High dose chemotherapy with ifosfamide,

High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults

✍ Jean-Pierre Droz; Pierre Biron; Jean-Pierre Lotz 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 2 views